A normal buyout might bring a pps of $1.20 to $1.25. That is a 50% premium, which is higher than average. You will see all kinds of nonsense about $3 and up, but that is just wishful thinking.
I think a more realistic scenario involves one or more surragates acquiring enough shares on the open market (for a lot less money) to effectively control the company, but not enough shares by any one of them to trigger any kind of poison pill. Then, look for a merger of some kind. If this happens, it will probably be before any positive data are released to the public ... which could be awhile.
At least, I hope that is what happens. I would prefer to see Iplex in strong hands. As you can no doubt see, I am not a fan of current management. Apparently, current management bought the science without doing enough DD and we (the stockholders, not management) have paid the price.
I like the science, but not the company.
News 
Market Data 
Discover 
AI
